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Studying gene expression at different hematopoietic stages provides
insights for understanding the genetic basis of hematopoiesis. We
analyzed gene expression in human CD34 hematopoietic cells that
represent the stem-progenitor population (CD34 cells).We collected
>459,000 transcript signatures from CD34 cells, including the de
novo-generated 3 ESTs and the existing sequences of full-length
cDNAs, ESTs, and serial analysis of gene expression (SAGE) tags, and
performed an extensive annotation on this large set of CD34
transcript sequences. We determined the genes expressed in CD34
cells, verified the known genes and identified the new genes of
different functional categories involved in hematopoiesis, dissected
the alternative gene expression including alternative transcription
initiation, splicing, and adenylation, identified the antisense and
noncoding transcripts, determined the CD34 cell-specific gene ex-
pression signature, and developed the CD34 cell-transcription map
in the human genome. Our study provides a current view on gene
expression inhumanCD34 cells and reveals that earlyhematopoiesis
is an orchestrated process with the involvement of over half of the
human genes distributed in various functions. The data generated
from our study provide a comprehensive and uniform resource for
studying hematopoiesis and stem cell biology.
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Hematopoiesis is a dynamic process. Formed in the ventralmesoderm at the embryonic stage, hematopoietic stem cells
migrate progressively to yolk sac, aortic region, placenta, fetal liver,
and bone marrow in the adult. During the process, the hematopoi-
etic stem cells reproduce themselves by self-renewal and differen-
tiate into the multipotent progenitors, the lineage-restricted pro-
genitors, and eventually the mature cell types of erythroid cell,
platelet, myeloid cell, monocyte, NK cell, T cell, and B cell in the
peripheral circulation to perform specified functions (1). CD34, a
cellular membrane glycoprotein, is a specific marker for the hema-
topoietic cells differentiated at the stem-progenitor stage in humans
and other mammalian species (2, 3). The CD34 hematopoietic
stem-progenitor cells (referred to as CD34 cells hereafter) are
essential for maintaining the entire hematopoietic system and are
widely used clinically to restore the hematopoietic system through
bone marrow transplantation for treatment of various diseases (4).
The functional importance of CD34 cells has attracted much
attention to determine the genetic basis of CD34 cells, as exem-
plified by analyzing gene expression in CD34 cells with increased
scope and identifying multiple genes and pathways associated with
CD34 cell-related hematopoietic self-renewal and differentiation
(5–15). However, the existing knowledge of gene expression in
CD34 cells is not comprehensive because the technologies used
are limited, the data generated are fractionated in individual studies
and lack consistent annotation with current genome information,
and the number of genes implicated as key genes associated with
CD34 cells remains very limited.
To gain more comprehensive knowledge of the genetic basis of
human CD34 cells, we performed an integrated transcriptome
analysis on human CD34 cells. We generated a large transcript
sequence dataset from human CD34 cells. Our extensive infor-
matics analysis of the sequence data reveals much novel informa-
tion on gene expression in CD34 cells and provides a current view
for the gene expression in CD34 cells and a comprehensive and
uniform resource for studying hematopoiesis and stem cell biology.
Results
The CD34 Transcript Sequences. Since CD34 cells were identified
as representing the hematopoietic stem-progenitor cells, continuing
efforts have identified the genes expressed in these cells with
substantial progress. However, because of the limitations of the
technologies, the existing data are not adequate to cover theCD34
transcriptome. We used the following 2 approaches to maximally
collect transcript sequences from CD34 cells:
i. De novoCD34 3EST collection:We performed a large-scale
CD34 3 EST collection from normal human hematopoietic
CD34 cells, using a high-throughput generation of long sequences
from serial analysis of gene expression (SAGE) tags for gene identifi-
cation (GLGI) method (16, 17). By using SAGE tags as the sense
primers forPCR,GLGIconvertsSAGEtags into3ESTs.From10,000
novel SAGE tags obtained in a previous CD34 study (12), we
generated25,798high-quality3ESTs.This is the largestESTcollection
from human CD34 cells and one of the largest EST collections from
a single human cell type using the Sanger sequencing system (http://
www.ncbi.nlm.nih.gov/UniGene/lbrowse2.cgi?TAXID  9606).
ii. Existing CD34 mRNA sequences collected: We performed
database and literaturemining to identify publicly available mRNA
sequences originating from human CD34 cells. These include
full-length cDNA sequences (8), 5 and 3 ESTs (7, 8, 16), 21-bp-
longSAGE tags (15), and 14-bp SAGE tags (10, 13). To ensure that
the information generated from the study represents the normal
CD34 transcriptome, we used only the sequences generated from
normal primary CD34 cells.
A total of 459,482 CD34 transcript signatures were identified
through these processes (Table 1, Dataset S1). They represent the
achievement of CD34 transcript identification in the past decade
using the Sanger sequencing system and provide a solid base for
comprehensive CD34 transcriptome annotation.
The Genes Expressed in CD34 Cells. We compared the CD34
transcript sequences with 22,828 human genes, including the 18,013
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human genes represented by 26,829RefSeqmRNA sequences and the
14,129humangenes representedby theSAGEmapreferencedatabase.
A total of 12,759 (56%)humangeneswerematchedby 221,017CD34
transcript sequences (Table 1, Dataset S2), indicating that over half of
the human genes are expressed in CD34 cells.
The Functional Categories for the Genes Expressed in CD34 Cells.Using
theGeneOntology reference database (18), we performed a global
functional classification for the genes expressed in CD34 cells
(Dataset S3). Under the ‘‘Cellular component’’ category, the genes
most commonly expressed were those involved in ‘‘cell,’’ ‘‘cell part,’’
‘‘organelle,’’ and ‘‘organelle part’’; under the ‘‘Biological process’’
category, the genes most commonly expressed were those involved
in ‘‘cellular process,’’ ‘‘metabolic process,’’ ‘‘biological regulation,’’
and ‘‘gene expression’’; under the ‘‘Molecular function’’ category,
the most commonly expressed genes were those involved in ‘‘bind-
ing,’’ ‘‘catalytic activity,’’ ‘‘molecular transducer activity,’’ and ‘‘tran-
scription regulator activity.’’ The broad functional categories imply
that CD34 cells execute many basic biological activities.
We further characterized several groups of functionally impor-
tant genes relating to hematopoiesis.
Genes Involved in Stem Cell Self-Renewal.Agroup of genes has been
clearly demonstrated to control self-renewal of hematopoietic stem
cells (5, 19). These genes include growth factors, chromatin asso-
ciation factors, homeobox genes, transcription factors, and cell cycle
regulators. Searching the CD34 gene list shows that 59 such genes
were detected (Dataset S4A). MYB is an important transcription
factor for hematopoiesis. It was detected by 12 ESTs, 6 SAGE tags
(33 copies), and 1 longSAGE tag (13 copies), indicating the
presence of multiple transcript isoforms from this gene in CD34
cells. MLL, a Drosophila trithorax homolog, methylates histone
H3K4 and regulates expression of many developmental genes
including HOX genes. It is frequently involved in acute leukemia
through chromosomal translocation. Five MLL isoforms were
detected in CD34 cells, of which 4 were detected by both EST and
SAGE tags. HOX genes are the master regulators of cellular
differentiation. Of the 39 human HOX genes, 14 were detected in
CD34 cells.Of those 14 genes,HOXA9,HOXA10, andHOXB4 are
known regulators of hematopoiesis, and the remaining 11 were
newly detected.
Transcription Factor Genes. Transcription factors are vital for gene
expression regulation. Comparing the 1,023 human transcription
factor genes grouped in 220 transcription factor families showed
that 574 (56%) transcription factor genes were expressed in CD34
cells (Dataser S4B). These 574 genes were distributed in 197 (90%)
transcription factor families (Table 2, Dataset S4C). zf-C2H2, a zinc
finger protein family, contains the largest number of genes of all
gene families; of the 574 genes detected, 327 belong to this family.
Signal Transduction Genes. We searched the CD34 gene list to
identify the genes involved in signal transduction pathways and
identified the genes involved in at least 10 pathways (Table 2,
Dataset S5A). Notch,Wnt, and TGFB pathways are well known to
regulate hematopoietic self-renewal and differentiation (5). Mul-
tiple genes involved in these pathways were detected (Dataset S5B).
An example is SMAD3, a gene involved in theWNTpathway. It was
detected by full-length cDNA, EST, and SAGE tags. More genes
involved in other signal transduction pathways were also detected.
For example, of the 79 known genes in the phosphatidylinositol
signaling system, 63 were detected in CD34 cells.
Kinase Genes. Protein kinases play essential roles in regulating a
wide range of biological activities. Of the 620 known human kinase
Table 1. The sequence sources and genes identified
in CD34 cells
Sequence type
Number
(%)
Matched
(%) Reference
Sources of CD34 transcript sequences
Full-length cDNA 298 (0.1) 8
ESTs
3 EST 25,798 Current study
3 EST 1,591 dbEST
3 EST 214 10
3 EST 177 6
5 EST 13,493 8
Oligo-capped 5 EST 1,295 14
EST 329 dbEST
Subtotal 42,897 (9)
SAGE tags
14-bp SAGE tag 99,954 10
14-bp SAGE tag 117,939 13
21-bp longSAGE tag 198,394 15
Subtotal 416,287 (91)
Total signature 459,482 (100)
Human genes matched by CD34 transcript sequences
Sequence type
Matched
genes
Full-length sequence 298 293 (98) 265
EST 42,897 10,273 (24) 4,989
SAGE tag 416,287 210,496 (51) 11,629
Total 459,482 221,017 (48) 12,759*
*The number refers to the nonredundant genes.
Table 2. Trancription factor, signal, and kinase genes
in CD34 cells
Items Total genes Detected* (%)
Examples of transcription factor gene families
zf-C2H2 549 327 (60)
KRAB 268 162 (60)
Homeobox 204 68 (33)
HLH 104 46 (44)
BTB 53 35 (66)
SCAN 50 34 (68)
Hormone receptor 48 29 (60)
zf-C4 48 29 (60)
bZIP 1 33 26 (79)
ETS 27 18 (67)
Fork head 47 18 (38)
PAS 18 15 (83)
TIG 14 13 (93)
PHD 14 12 (86)
GATA 14 11 (79)
MYB DNA-binding 17 11 (65)
Signal pathway genes detected in CD34 cells
Calcium signaling pathway 176 44 (25)
ERB B signaling pathway 87 29 (33)
Hedgehog signaling pathway 57 12 (21)
JAK-STAT signaling pathway 155 35 (23)
MAPK signaling pathway 265 66 (25)
mTOR signaling pathway 51 14 (27)
Notch signaling pathway 46 12 (26)
Phosphatidylinositol signaling system 79 63 (80)
TGF- signaling pathway 89 27 (30)
VEGF signaling pathway 73 20 (27)
WNT signaling pathway 148 50 (34)
Kinase genes detected in CD34 cells
AGC 69 6 (9)
Atypical 39 9 (23)
Calcium/calmodulin regulated kinases 113 10 (9)
Casein kinase 1 17 5 (29)
CMGC 76 9 (12)
Receptor guanylate cyclase 8 0 (0)
STE 53 10 (19)
Tyrosine kinase-like 49 11 (22)
Tyrosine kinases 95 18 (19)
Other 101 15 (15)
Total 620 (100) 94 (15)
*The same genes can be classified in different families.
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genes (20), 94 were detected in CD34 cells (Table 2, Dataset S5
C–E), including 19% of tyrosine kinase genes. FLT3 is a receptor
tyrosine kinase that regulates self-renewal of hematopoietic stem
cells, and it is frequently mutated in acute myeloid leukemia.
Studies in mouse and human cells have not determined the specific
hematopoietic stages for FLT3 expression (21). The detection of
FLT3 transcripts by bothEST and longSAGE inCD34 cells indicates
thatFLT3 isexpressedat thestem-progenitorstages. Interestingly,none
of the 8 kinase genes belonging to the receptor guanylate cyclase were
detected in CD34 cells. It remains to be determined if this type of
kinase plays no role in early hematopoiesis.
microRNA Genes. Evidence shows that microRNAs are involved in
regulating hematopoiesis (22, 23). The primary microRNA tran-
scripts are processed by 5 capping and 3 polyadenylation into the
precursors before being further processed into mature microRNA
(24). Matching CD34 ESTs and SAGE tags to known human
microRNA precursor sequences identifies 45 microRNAs ex-
pressed in CD34 cells, most of which are not known to relate to
hematopoiesis (Dataset S6 A–C). Several microRNA precursors
are present at high levels, such as hsa-mir-566 (45 EST copies and
56 SAGE copies), hsa-mir-619 (53 EST copies and 187 SAGE
copies), and hsa-mir-1273 (195 EST copies). Their high abundance
suggests their functional importance in regulating early hemato-
poiesis.
Alternative Transcription. The coding sequences of known genes in
the genomic DNA have defined structures. However, the tran-
scripts expressed from the genomic coding sequences can be
substantially different because of transcriptional regulation. The
resulting transcript isoforms substantially increase genomic com-
plexity and can result in altered biological activities. We addressed
this issue by analyzing differential transcriptional initiation, alter-
native splicing and adenylation, and antisense and noncoding
transcription.
Alternative transcriptional initiation. A set of 1,090 5 ESTs was
generated from an oligo-capping CD34 cDNA library (CD34C,
ref. 16). Our evaluation of those sequences with human 5 cap-
analysis gene expression (CAGE) tags shows that the 5 ends of
83% of the sequences map to 5 CAGE tags, confirming that the
5 ESTs from this CD34 library provide high-quality bona fide 5
end information. A total of 503 promoters for 495 genes were
identified by the 1,090 5 ESTs, of which 157 belong to the genes
with a single promoter and 346 belong to the genes with multiple
promoters. Of the 503 promoters, 333 are TATA CpG, 52 are
TATA CpG, 27 are TATA CpG, and 91 are TATA
CpG (Table 3, Dataset S7A). The distribution pattern is consis-
tent with that for most human genes (25). IL2RA (interleukin-2
receptor alpha subunit) is a gene important for interleukin 2-reg-
ulated T cell proliferation. A promoter of this gene identified by a
5 EST (DA419380) is TATA CpG. The wide use of multipro-
moter genes with atypical promoter structure suggests that alter-
native transcriptional initiation is commonly used by the genes
expressed in CD34 cells.
Alternative Splicing and Adenylation. Alternative splicing and ad-
enylation are 2 mechanisms of posttranscriptional regulation (26).
A 3 EST is located at the 3 end of the detected transcript. Their
Table 3. Alternative gene expression in CD34 cells
Type Mapped sequences (%) Mapped by Upstream (%) 3 end (%) Mapped antisense (%) Mapped noncoding (%)
A. Alternative initiation
5 EST 1,090
Mapped promoter 503 (100)
Single promoter gene 157 (31)
Multiple promoter gene 346 (69)
Promoter structure
TATA, CpG island 333
TATA, CpG island 27
TATA, CpG island 91
TATA, CpG island 52
B. Alternative splicing and adenylation
3 EST 2,786 (100) 894 (32) 1,892(68)
SAGE tag 11,136 (100) 8,118 (73) 3,018(27)
longSAGE tag 7,512 (100) 3,723 (50) 3,788(50)
C. Antisense transcription
Known antisense transcripts 7,356 (100)
EST 697 441
SAGE tag 1,346 1,478
longSAGE tag 993 993
Total 1,864 (25)*
D. Noncoding transcripts
Known noncoding transcripts 2,354 (100)
EST 958 660
SAGE tag 345 405
longSAGE tag 112 144
Total 923 (39)*
*The numbers refer to nonredundant sequences.
Table 4. CD34-specific gene expression signature: Differences
between CD34 cells and multiple cell types*
Comparison to
Expression status in CD34 cells
TotalPresent High Absent Low
ES cells 1,077 436 1,257 1,063 3,833
Erythroids 327 198 387 306 1,218
Monocyte 767 269 522 568 2,126
Immature dendritic cells 486 299 897 677 2,359
Mature dendritic cells 229 177 484 391 1,281
CD4 T cells 396 254 714 397 1,761
CD8 T cells 394 216 682 481 1,773
NK cells 276 178 482 491 1,427
B cells 393 255 712 543 1,903
Myeloid cells 507 535 711 565 2,318
Total 4,852 2,817 6,848 5,482 19,999
*Each tag is determined under P  0.05 and fold change  3 between CD34
and given cell type. ES, embryonic stem cells; ER, erythroid cells; MC, mono-
cytes; ID, inmature dendritic cells; MD, mature dendritic cells; CD4 T, CD4 T
cells; CD8 T, CD8 T cells; B, B cells; Mye, myeloid cells.
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3 end location in themappedRefSeq can be used to determine the
alternatively spliced and/or adenylated transcripts; a SAGE tag is
located at the 3 end after the last CATG of the detected transcript.
A SAGE tag matching to the upstream CATG position of the
RefSeq implies that the SAGE tag is derived from an alternatively
spliced or adenylated transcript. Mapping the poly(A) signal  3
ESTs to RefSeq shows that 28% of the 3 ESTs matched upstream
of the 3 ends (Table 3, Dataset S7B). FTH1 (NM002032) repre-
sents an example. Of the 7 ESTs mapped to its 1,245-base full-
length sequence, all matched 297 bases upstream of the 3 end.
SAGE tag mapping shows that 50–73% of the SAGE tags matched
upstream locations (Table 3, Dataset S7 C andD). For example, of
the 5 SAGE tags matching to the FOXK1 sequence
(NM001037165), 4 matched upstream CATG sites and 1 matched
the 3-end CATG site (Dataset S7C).
Antisense and Noncoding Transcripts. Antisense transcription is a
mechanism for gene expression regulation. Up to 70% of human
genes have been shown to express antisense transcripts (27). Using
the 7,356 well-annotated antisense sequences as the reference, 25%
are mapped by CD34 ESTs and SAGE tags (Table 3, Dataset
S8A). AA687703, an antisense transcript toCSDE1, wasmapped by
an EST, a SAGE tag, and a longSAGE tag. Noncoding transcripts
are involved in gene expression regulation, RNA editing, genomic
imprinting and epigenetic activities (32), and stem cell differenti-
ation (28). Of the 2,354 known noncoding transcript sequences,
39%aremapped byCD34ESTs and SAGE tags (Table 3,Dataset
S8B). For example, a noncoding xi transcript AF001545 was
detected by a SAGE tag and a longSAGE tag.
CD34 Cell-Specific Gene Expression Signatures. Reflecting the dy-
namic process of hematopoietic differentiation, the spectrum of the
transcriptome changes at different stages. We compared gene
expression between CD34 cells, upstream embryonic stem cells,
and downstream mature hematopoietic cell types. SAGE tags
provide both high coverage and quantitative information and were
used for the comparison. The results show that CD34 cells do have
specific expression signatures, as reflected by the differences of
thousands of SAGE tags between CD34 cells and other cell types
(Table 4, Dataset S9). Detailed comparison identified a set of core
genes that distinguishes CD34 cells from multiple cell types,
including 220 genes highly or only detected in CD34 cells and 98
genes highly or only detected in other cell types (Table 5, Dataset
S9B). The functional categories of these genes cover a wide range.
These genes provide new candidate genes associated with early
hematopoiesis and new candidate genemarkers specific for CD34
cells. HLA-DRA, an MHC class II gene, plays a critical role in
antigen presentation in the immune reaction. However, the highest
expression level of this gene is in CD34 cells but not in antigen
presenting cell types. XIST encodes noncoding transcripts that
silence one of the 2 X chromosomes through X chromosome
imprinting. XIST is considered to be active only at the early
embryonic stages. The high-level expression of multiple XIST
transcript isoforms in CD34 cells as reflected by 3 different SAGE
tags at 32, 13, and 10 copies (Dataset S9B) supports the notion that
XIST is reactivated in early hematopoiesis (29).
CD34 Cell Transcription Map. We developed a CD34 cell tran-
scription map that provides a genomewide view for the transcrip-
tion activities in CD34 cells. The map contains detailed mapping
information, including the CD34 transcript-detected genes with
their corresponding exon, intron, antisense, promoter, 5, and 3
ends, and the CD34 transcript-mapped intergenic region repre-
senting novel transcribed loci (Dataset S10). The map is integrated
into the University of California, Santa Cruz (UCSC) human
genome browser and can be visualized from the whole-
chromosome to the single-base levels (http://projects.bioinformat-
ics.northwestern.edu/wanglab/CD34plus/). By selecting the items
listed in the genome browser, the information related to the
mapped transcripts can be selected. Comparing the general tran-
scriptional information listed in the browser, the CD34 cell
transcription map shows the commonality and differences between
the known transcribed loci and the CD34-specific transcribed loci.
Fig. 1 shows the CD34 transcription map of chromosome 21.
Table 5. CD34-specific gene expression signature: Examples of the signature genes between CD34 cells and multiple cell types
Gene SAGE tag
SAGE tag copy*
CD34 ES ER MC ID MD CD4 T CD8 T NK B Mye
High in CD34 cells
ANXA11 TGGCGTACGG 97 1 — 4 — 3 6 — 3 4 9
ATCAY GGGACCACCG 26 — — — — — — — — — —
EEF1A1 TTTTTGATAA 156 8 — 2 1 1 2 2 — 1 34
HLA-DRA ATTCCTGAGC 17 — 2 — 4 — — — 1 — —
HMGB1 TCTGCTAAAG 58 19 3 2 5 — 2 1 — — —
HSPD1 CTCTTAAAAG 32 — 1 — — — — — — — 2
KIF5C GAGCGGCGCT 114 — — — — — — — — — —
MALAT1 CCAGAGAACT 165 — 29 11 13 4 7 2 2 1 —
MPO GCTCCCCTTT 126 — 10 — — — — — — — 37
PRDX1 ACCCGCCGGG 918 6 6 10 24 8 3 1 4 1 103
SET GAGTAGAGAA 17 — — 2 5 — 3 — — 3 —
SP1 ATGATCTGCC 13 1 1 — 3 — — — — — —
UBQLN1 TCTTTTATTA 27 — — 2 — — — — — — 10
XIST GGTGACCACC 32 — — — — — — — — — 6
Low in CD34 cells
APOE CGACCCCACG — 62 9 7 44 16 4 — — — —
CALM1 CAGCTTGACG — 13 — — 11 12 8 6 5 4 7
CBLB GTGACCACGG — 22 18 50 319 51 108 14 17 5 2,866
CXCR4 TTAAACTTAA 3 — — 13 — 11 35 30 12 89 20
HLA-C GTGCGCTGAG 11 4 — 174 79 173 165 230 226 84 4
HMOX1 CGTGGGTGGG — 4 — 31 31 17 — — 3 — 9
JUNB ACCCACGTCA 1 — — 49 14 24 51 44 10 52 21
MAP2K2 CAGGAACGGG 2 11 5 10 8 6 5 — 10 11 —
MAP4K3 CAAATCCAAA — 10 — 4 7 213 42 42 31 26 —
NFKB2 GGAAGGGGAG — 9 — — 5 8 13 12 — 62 —
S100A10 AGCAGATCAG 2 14 — 77 63 37 8 18 22 — 33
TNFRSF1B ATGGAGCGCA — — — 38 3 11 4 — 13 — 26
*Please see Table 4 for details.
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Discussion
Our study used normal CD34 transcript sequences of full-length
cDNA,EST,andSAGEtagscollectedby theSangersequencingsystem
(30). By analyzing the integrated CD34 transcript sequences with the
current genome information, our study provides a comprehensive view
on the CD34 transcriptome. Data from the study show that early
hematopoiesis is an orchestrated process involving over half of the
human genes and indicate that systems approaches will be required to
fully reveal the genetic base of hematopoiesis.
Two issues need to be considered for this study. One is the nature
of CD34 cells, and the other is the comprehensiveness of the data.
CD34 cells are not a homogeneous but a heterogeneous popula-
tion covering stem cells, earlier multipotent progenitors, and later
lineage-restricted progenitors. Using more specific markers,
CD34 cells can be classified into narrower differentiation stages.
Although it would be ideal to analyze the cells at more specific
stages, the increased rarity of such cells restricts their practical usage
for large-scale transcriptome studies. Developing new approaches,
such as single cell-based assays for transcript isolation, and collect-
ing sequences by using next-generation DNA sequencers that
demand less input material than the Sanger sequencer could
improve the situation. Like transcriptome studies in most human
cell types, our current study does not cover the entire CD34
transcriptome. This is illustrated by the absence of certain genes
known to play roles in early hematopoiesis. For example, multiple
microRNAs are involved in regulating hematopoiesis, but many are
A
B
Fig. 1. CD34 cell transcriptionmap in chromosome 21. (A) The positions of full-length cDNA, EST, and longSAGE tags in chromosome 21 of hg18. The RefSeq in the
bottom line represents the known human genes. Themap is integrated in the UCSC human genome browser. (B) A zoom-in view of themapped transcripts at a locus
containing AML1/RUNX1, the gene important for early hematopoiesis. Of the 5 ESTs mapped to this gene, 1 maps to the 3 end but in an antisense orientation, and
4 map to the first intron; of the 17 mapped longSAGE tags, 2 map to the 3 end, and 15 map to different introns of which 5 are in antisense orientation.
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not included in the microRNA dataset from the current study (23).
Our current study targeted only the poly(A) mRNAs. Increasing
evidence shows that different types of transcripts exist, such as the
regulatory small RNAs (31). Those transcripts do not contain
poly(A) tails [poly(A)] (32) and cannot be detected by the
poly(A)-based approach. In addition, at a given sequencing scale,
certain functionally important genes expressed at lower abundance
will be under the threshold of detection. The next-generation
sequencers provide much higher throughput capacity. Their appli-
cation should increase transcriptome coverage.
Methods
De Novo Collection of CD34 3 ESTs. Bone marrow CD34 cells of 3 healthy
donors were purchased from AllCells. 3 ESTs were collected by using the GLGI
method (18, 19). A total of 10,000CD34 SAGE tags identified in aprevious study
(12) were selected as the sense primers for the GLGI reactions on the basis of the
following conditions: i. Each tag should map to the human genome sequences.
This will provide a minimal guarantee that the SAGE tag is likely to be from
transcripts expressed from the human genome. ii. There should be no poly(A)
track (7 consecutive A’s) 200 bp downstream of the tag-mapped location (33).
This restriction will help to exclude the SAGE tags from the cDNA generated by
internal oligo(dT) priming. iii. It should not map to known human mRNA se-
quences. This will increase the chance of identifying novel transcripts.
Sources of Existing Transcript Sequences from Human CD34 and Other Cell
Types. Full-length cDNA, ESTs, and SAGE tags from normal human CD34 cells
weredownloadedfromNCBIEntrez(http://www.ncbi.nim.nih.gov/Entrez).SAGE
data fromother cell typesweredownloaded fromNCBIGEO (http://www.ncbi.n-
im.nih.gov/geo). Statistical SAGE data comparisons were performed using the
IDEG6 program (http://telethon.bio.unipd.it/bioinfo/IDEG6/) under the cutoff of
P 0.05 and fold change3 between datasets.
Reference Databases Used for the Analyses. The RefSeq mRNA sequences of
‘‘REVIEWED’’ and ‘‘VALIDATED’’ were downloaded from http://www.
genome.ucsc.edu. The ‘‘SAGEmap reliable’’ database was downloaded from
http://www.ncbi.nlm.nih.gov/projects/SAGE/. The Gene Ontology database was
downloaded from http://www.geneontology.org/. The transcription factor
genes were downloaded from http://dbd.mrc-lmb.cam.ac.uk/DBD/. The genes in
signal transduction pathways were downloaded from http://www.genome.jp/
kegg/pathway.html. Kinase genes were downloaded from http://kinase.com/
human/kinome/. microRNA precursor sequences were downloaded from miR-
base under ‘‘hairpin sequences’’ (http://microrna.sanger.ac.uk/sequences/). To
identify SAGE tag-detected microRNAs, the hairpin sequences were extended
with 30-bp genomic sequences at both 5 and 3 ends to increase the chance of
finding the CATG site (27). Reference SAGE tagswere then extracted next to the
identified CATG sites. The CAGE database was downloaded from http://
gerg01.gsc.riken.jp/cage/hg17prmtr/. The database of transcription start sites
was downloaded from http://dbtss.hgc.jp/. Antisenses were downloaded from
http://natsdb.cbi.pku.edu.cn. Noncoding transcripts were downloaded from
http://research.imb.uq.edu.au/RNAdb.
Determining Alternative Splicing and Adenylation. Each 3 EST was examined for
thepoly(A) signal10–30basesupstreamfromthe3end in theorderofAATAAA,
ATTAAA, TATAAA, AGTAAA, AAGAAA, AATATA, AATACA, CATAAA, GATAAA,
AATGAA, TTTAAA,ACTAAA,AATAGA (26). The 3 ESTsweremappeddirectly to
the RefSeq mRNA sequences. The 3 ESTs that ended within 10 bp of the
mapped RefSeq sequences were classified to represent the 3 ends, and those
mapped farther upstream were classified to represent alternative spliced se-
quences. To identify SAGE tag-detected alternatively spliced transcripts, 14- or
21-bp reference SAGE tags were extracted after all CATG sites in the RefSeq
sequences.
GenomeMapping. Full-lengthcDNAsequencesandESTsweremappeddirectly to
hg18,andlongSAGEtagsweremappedtothereference longSAGEtagsextracted
from all CATG sites in hg18. The mapping is chromosome based and integrated
into the UCSC genome browser with its all selectable features.
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